{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:17:09Z","timestamp":1771456629716,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701089"],"award-info":[{"award-number":["81701089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772449"],"award-info":[{"award-number":["81772449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960246"],"award-info":[{"award-number":["81960246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971081"],"award-info":[{"award-number":["81971081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260258"],"award-info":[{"award-number":["82260258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2017GXNSFBA198010"],"award-info":[{"award-number":["2017GXNSFBA198010"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2020GXNSFAA238003"],"award-info":[{"award-number":["2020GXNSFAA238003"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20180307154606793"],"award-info":[{"award-number":["JCYJ20180307154606793"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["KQTD20190929173853397"],"award-info":[{"award-number":["KQTD20190929173853397"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.trsl.2023.05.003","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T11:57:09Z","timestamp":1684497429000},"page":"32-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["GABAergic signaling abnormalities in a novel CLU mutation Alzheimer's disease mouse model"],"prefix":"10.1016","volume":"260","author":[{"given":"Chunxia","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihe","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meicun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2023.05.003_bib0001","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1474-4422(21)00263-5","article-title":"Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"20","author":"Kehoe","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.trsl.2023.05.003_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2022.12.003","article-title":"Vascular contributions to Alzheimer's disease","volume":"254","author":"Eisenmenger","year":"2023","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2023.05.003_bib0003","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"Alzheimer\u2019s Association. 2021 Alzheimer\u2019s disease facts and figures","volume":"17","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.trsl.2023.05.003_bib0004","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/brain\/awaa223","article-title":"Phosphorylated tau interactome in the human Alzheimer's disease brain","volume":"143","author":"Drummond","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.trsl.2023.05.003_bib0005","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/nn.4137","article-title":"Rescue of long-range circuit dysfunction in Alzheimer's disease models","volume":"18","author":"Busche","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0006","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","article-title":"Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice","volume":"30","author":"Andrews-Zwilling","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0007","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature09612","article-title":"Regulation of synaptic connectivity by glia","volume":"468","author":"Eroglu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2023.05.003_bib0008","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nm.3639","article-title":"GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease","volume":"20","author":"Jo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2023.05.003_bib0009","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.1169096","article-title":"Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice","volume":"323","author":"Kuchibhotla","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.trsl.2023.05.003_bib0010","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2023.05.003_bib0011","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1074\/jbc.M111.309385","article-title":"\u03b3-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation","volume":"287","author":"Nyk\u00e4nen","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2023.05.003_bib0012","doi-asserted-by":"crossref","first-page":"eaao4827","DOI":"10.1126\/science.aao4827","article-title":"Secreted amyloid-\u03b2 precursor protein functions as a GABA(B)R1a ligand to modulate synaptic transmission","volume":"363","author":"Rice","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.trsl.2023.05.003_bib0013","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2023.05.003_bib0014","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","article-title":"The multiplex model of the genetics of Alzheimer's disease","volume":"23","author":"Sims","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0015","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/bi00474a025","article-title":"Apolipoprotein J: structure and tissue distribution","volume":"29","author":"de Silva","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.trsl.2023.05.003_bib0016","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1523\/JNEUROSCI.5236-13.2014","article-title":"Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly","volume":"34","author":"Roussotte","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0017","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jalz.2014.10.012","article-title":"Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals","volume":"11","author":"Lancaster","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.trsl.2023.05.003_bib0018","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s40478-020-01079-1","article-title":"Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation","volume":"8","author":"Wojtas","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.trsl.2023.05.003_bib0019","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2023.05.003_bib0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.stem.2019.04.014","article-title":"OLIG2 drives abnormal neurodevelopmental phenotypes in human iPSC-based organoid and chimeric mouse models of Down Syndrome","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trsl.2023.05.003_bib0021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.abb8575","article-title":"Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets","volume":"370","author":"Sierksma","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.trsl.2023.05.003_bib0022","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.trsl.2013.11.001","article-title":"Regenerative medicine in Alzheimer's disease","volume":"163","author":"Felsenstein","year":"2014","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2023.05.003_bib0023","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrm3448","article-title":"Induced pluripotent stem cells: the new patient?","volume":"13","author":"Bellin","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2023.05.003_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101462","article-title":"Modeling sporadic Alzheimer's Disease in human brain organoids under serum exposure","volume":"8","author":"Chen","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0025","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","article-title":"Modeling amyloid beta and tau pathology in human cerebral organoids","volume":"23","author":"Gonzalez","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.trsl.2023.05.003_bib0026","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41380-019-0410-8","article-title":"Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta","volume":"25","author":"Arber","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.trsl.2023.05.003_bib0027","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-018-0265-5","article-title":"iPSC-derived familial Alzheimer's PSEN2 (N141I) cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling","volume":"13","author":"Moreno","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.trsl.2023.05.003_bib0028","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's Disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.trsl.2023.05.003_bib0029","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1093\/brain\/awv222","article-title":"Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations","volume":"138","author":"Iovino","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.trsl.2023.05.003_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2023.05.003_bib0031","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1038\/s41467-020-19227-5","article-title":"Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease","volume":"11","author":"McQuade","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2023.05.003_bib0032","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41467-018-07971-8","article-title":"CRISPR\/Cas9 editing of APP C-terminus attenuates \u03b2-cleavage and promotes \u03b1-cleavage","volume":"10","author":"Sun","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2023.05.003_bib0033","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2023.05.003_bib0034","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","article-title":"APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2023.05.003_bib0035","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jamaneurol.2014.2802","article-title":"Human neurons derived from induced pluripotent stem cells as a new platform for preclinical drug screening and development","volume":"71","author":"Liao","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.trsl.2023.05.003_bib0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-016-0106-3","article-title":"Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy","volume":"11","author":"Yang","year":"2016","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.trsl.2023.05.003_bib0037","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.7150\/thno.26643","article-title":"Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model","volume":"8","author":"Yuan","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.trsl.2023.05.003_bib0038","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nmeth.2283","article-title":"Generation of integration-free neural progenitor cells from cells in human urine","volume":"10","author":"Wang","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.trsl.2023.05.003_bib0039","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/nprot.2012.121","article-title":"Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression","volume":"7","author":"Dowey","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.trsl.2023.05.003_bib0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","article-title":"Disease-associated astrocytes in Alzheimer's disease and aging","volume":"23","author":"Habib","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0041","doi-asserted-by":"crossref","first-page":"eaav0316","DOI":"10.1126\/sciadv.aav0316","article-title":"Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease","volume":"5","author":"Park","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.trsl.2023.05.003_bib0042","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.trsl.2023.05.003_bib0043","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.410210403","article-title":"Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease","volume":"21","author":"Perry","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.trsl.2023.05.003_bib0044","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002100000346","article-title":"Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology","volume":"363","author":"Seidl","year":"2001","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.trsl.2023.05.003_bib0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s007020050073","article-title":"Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease","volume":"105","author":"Jim\u00e9nez-Jim\u00e9nez","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1016\/j.trsl.2023.05.003_bib0046","first-page":"156","article-title":"Early detection of dementia in multilingual populations: Visual Cognitive Assessment Test (VCAT)","volume":"87","author":"Kandiah","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.trsl.2023.05.003_bib0047","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/ptr.3183","article-title":"Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid \u03b2-induced neurite atrophy","volume":"24","author":"Urano","year":"2010","journal-title":"Phytother Res"},{"key":"10.1016\/j.trsl.2023.05.003_bib0048","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fnins.2018.00504","article-title":"Clusterin is required for \u03b2-Amyloid toxicity in human iPSC-derived neurons","volume":"12","author":"Robbins","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107962","article-title":"In vivo chimeric Alzheimer's Disease modeling of apolipoprotein E4 toxicity in human neurons","volume":"32","author":"Najm","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2023.05.003_bib0050","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/cn500148z","article-title":"The role of tau oligomers in the onset of Alzheimer's disease neuropathology","volume":"5","author":"C\u00e1rdenas-Aguayo Mdel","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0051","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","article-title":"Accumulation of pathological tau species and memory loss in a conditional model of tauopathy","volume":"27","author":"Berger","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0052","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s004010050815","article-title":"Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study","volume":"95","author":"Giannakopoulos","year":"1998","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.trsl.2023.05.003_bib0053","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0054","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.neuron.2017.02.001","article-title":"Hallmarks of Alzheimer's Disease in stem-cell-derived human neurons transplanted into mouse brain","volume":"93","author":"Espuny-Camacho","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.trsl.2023.05.003_bib0055","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2023.05.003_bib0056","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-019-0498-8","article-title":"Peripheral administration of human recombinant ApoJ\/clusterin modulates brain beta-amyloid levels in APP23 mice","volume":"11","author":"de Retana","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.trsl.2023.05.003_bib0057","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.1711357114","article-title":"Role of clusterin in the brain vascular clearance of amyloid-\u03b2","volume":"114","author":"Nelson","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2023.05.003_bib0058","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1073\/pnas.1204606109","article-title":"Loss of functional GABA(A) receptors in the Alzheimer diseased brain","volume":"109","author":"Limon","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2023.05.003_bib0059","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid (A) receptors: classification on the basis of subunit composition, pharmacology, and function","volume":"60","author":"Olsen","year":"2008","journal-title":"Update. Pharmacol Rev"},{"key":"10.1016\/j.trsl.2023.05.003_bib0060","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/0028-3908(83)90115-6","article-title":"GABAergic synapses. Supramolecular organization and biochemical regulation","volume":"22","author":"Guidotti","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.trsl.2023.05.003_bib0061","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA (A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0062","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.stem.2009.10.003","article-title":"Imbalance between GABAergic and Glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer's Disease","volume":"5","author":"Sun","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trsl.2023.05.003_bib0063","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/383283","article-title":"Variations in GABRA2, encoding the alpha 2 subunit of the GABA (A) receptor, are associated with alcohol dependence and with brain oscillations","volume":"74","author":"Edenberg","year":"2004","journal-title":"Am J Hum Gene"},{"key":"10.1016\/j.trsl.2023.05.003_bib0064","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1038\/s41467-018-05481-1","article-title":"Developmental seizures and mortality result from reducing GABA(A) receptor \u03b12-subunit interaction with collybistin","volume":"9","author":"Hines","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2023.05.003_bib0065","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/s41386-018-0160-3","article-title":"TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA (A) receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia","volume":"43","author":"Rajagopal","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.trsl.2023.05.003_bib0066","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jnc.14325","article-title":"GABA (A) receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus","volume":"145","author":"Kwakowsky","year":"2018","journal-title":"J Neurochem"},{"key":"10.1016\/j.trsl.2023.05.003_bib0067","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1093\/brain\/aws210","article-title":"Decreased carbon-11-flumazenil binding in early Alzheimer's disease","volume":"135","author":"Pascual","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.trsl.2023.05.003_bib0068","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2023.05.003_bib0069","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2023.05.003_bib0070","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer's disease","volume":"31","author":"He","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.trsl.2023.05.003_bib0071","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1016\/j.bmcl.2015.08.039","article-title":"Mechanism of action of antiepileptic ceramide from Red Sea soft coral Sarcophyton auritum","volume":"25","author":"Eltahawy","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.trsl.2023.05.003_bib0072","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1080\/15548627.2022.2136821","article-title":"LC3\/GABARAP binding to fluid membranes is potentiated by ceramide","volume":"19","author":"Varela","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.trsl.2023.05.003_bib0073","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.neuroscience.2006.05.007","article-title":"Interleukin-1beta induces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons","volume":"141","author":"Tabarean","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.trsl.2023.05.003_bib0074","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/j.1460-9568.2007.05797.x","article-title":"Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons","volume":"26","author":"Patil","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2051-5960-2-9","article-title":"Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis","volume":"2","author":"Couttas","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.trsl.2023.05.003_bib0076","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","article-title":"The role of ceramide and sphingosine-1-phosphate in Alzheimer's Disease and other neurodegenerative disorders","volume":"56","author":"Czubowicz","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.trsl.2023.05.003_bib0077","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jchromb.2007.09.027","article-title":"Evaluation of sphingolipids changes in brain tissues of rats with pentylenetetrazol-induced kindled seizures using MALDI-TOF-MS","volume":"859","author":"Ma","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.trsl.2023.05.003_bib0078","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/nprot.2013.106","article-title":"Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells","volume":"8","author":"Liu","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.trsl.2023.05.003_bib0079","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/ncomms3196","article-title":"hESC-derived Olig2+ progenitors generate a subtype of astroglia with protective effects against ischaemic brain injury","volume":"4","author":"Jiang","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2023.05.003_bib0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.stem.2019.09.003","article-title":"Oligodendrocyte death in Pelizaeus-Merzbacher Disease is rescued by iron chelation","volume":"25","author":"Nobuta","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trsl.2023.05.003_bib0081","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41422-021-00532-7","article-title":"Degradation of lipid droplets by chimeric autophagy-tethering compounds","volume":"31","author":"Fu","year":"2021","journal-title":"Cell Res"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:47:45Z","timestamp":1761828465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524423000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":81,"alternative-id":["S1931524423000877"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2023.05.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GABAergic signaling abnormalities in a novel CLU mutation Alzheimer's disease mouse model","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2023.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}